Enhanced multi-label cardiology diagnosis with channel-wise recurrent fusion

Weimin Wen1, Hongyi Zhang1, Zidong Wang2

  • 1School of Opto-Electronic and Communication Engineering, Xiamen University of Technology, Xiamen 361024, China.

PubMed

Insights

This study introduces the Branched Convolution and Channel Fusion Network (BCCF-Net) for advanced electrocardiogram (ECG) analysis. The novel network accurately identifies multiple heart conditions simultaneously from ECG signals.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Signal Processing

Background:

  • Timely detection of abnormal electrocardiogram (ECG) signals is crucial for preventing heart disease.
  • Traditional automated methods struggle with simultaneous multi-disease identification and 12-lead ECG correlations.

Purpose of the Study:

  • To present a novel network architecture, the Branched Convolution and Channel Fusion Network (BCCF-Net), for multi-label ECG diagnosis.
  • To enable simultaneous identification of multiple cardiac diseases from ECG signals.
  • To explore potential correlations within 12-lead ECG signals.

Main Methods:

  • Developed the Branched Convolution and Channel Fusion Network (BCCF-Net).
  • Incorporated Channel-wise Recurrent Fusion (CRF) to enhance 12-lead correlation analysis.
  • Utilized squeeze and excitation (SE) attention mechanism within convolutional neural networks (CNNs).
  • Employed multi-branch convolution (MBC) modules for capturing multi-scale spatio-temporal patterns.

Main Results:

  • The BCCF-Net demonstrated superior performance compared to state-of-the-art algorithms on two public datasets.
  • Achieved high efficacy and robustness in multi-label ECG classification across seven subtasks.
  • The framework successfully identified multiple diseases simultaneously from ECG segments.

Conclusions:

  • The BCCF-Net offers a significant advancement in automated ECG analysis for multi-label diagnosis.
  • The proposed framework has practical clinical applications for refined cardiac arrhythmia diagnosis.
  • This approach enhances the diagnostic capabilities for complex cardiovascular conditions using ECG data.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...